Scilex Holding (NASDAQ:SCLXW – Get Free Report)’s stock price was up 2% during mid-day trading on Wednesday . The stock traded as high as $0.21 and last traded at $0.2090. 5,026 shares traded hands during trading, a decline of 8% from the average session volume of 5,488 shares. The stock had previously closed at $0.2049.
Scilex Price Performance
The company’s 50-day simple moving average is $0.17 and its 200 day simple moving average is $0.15.
About Scilex
Scilex Holding Company is a specialty pharmaceutical firm focused on the commercialization, licensing and distribution of branded products for the management of acute and chronic pain. Established through a series of strategic acquisitions and internal development efforts, the company concentrates on non-opioid, topical and systemic therapies designed to address unmet needs in neuropathic and musculoskeletal pain. Scilex partners with healthcare providers, pharmacies and specialty distributors to bring its portfolio to patients across the United States.
The company’s flagship product, ZTlido® (lidocaine topical system 1.8%), is an FDA-approved prescription patch indicated for the relief of pain associated with postherpetic neuralgia.
See Also
- Five stocks we like better than Scilex
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
